Terms: = Breast cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Prognosis
4 results:
1. mnx1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive breast cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean breast cancer Society.
Kang YJ; Oh SJ; Choi H; Cho S; Shin CH; Kim C; Woo J; Lee J; Park HK; Lee HB; Noh WC; Kim YS
Breast Cancer Res Treat; 2021 Feb; 186(1):125-134. PubMed ID: 33389401
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA mnx1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract] [Full Text] [Related]
4. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
[TBL] [Abstract] [Full Text] [Related]
